Treatments that mimic GLP-1 can assist with type 2 diabetes and weight management, but consulting with a healthcare provider is essential before starting
Not a huge difference on paper, but clinically significant for both efficacy and side effects
that bone loss was most pronounced in weight-bearing skeletal sites, with no significant changes in non-weight-bearing areas such as the radius, suggests that mechanical unloading may be a key driver of bone resorption rather than a direct pharmacologic effect of GLP-1 receptor activation
The most practical fix is simply moving your injection day
It has demonstrated neuroprotective effects [133,134,135,136] and mimicked NACs effects in a neurodevelopmental schizophrenia model [85], supporting the involvement of oxidative stress in the progression of cognitive impairments
cagrilintides long-term safety is simply not yet established